Australia, Jan. 13 -- Telix Pharmaceuticals Ltd., owns the trademark (2553325) for 'PIXLUMI' till June 4, 2035.
Status: registered:
Registered/protected
Classes: 5 [chemical products for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations] and 10 [medical devices for the preparation and administration of radioactive diagnostic agents for the treatment of cancer; diagnostic imaging apparatus for medical use; medical apparatus; medical apparatus for introducing pharmaceutical preparations into the human body; applicators for pharmaceutical preparations; medical instruments]
Type of Mark: Word
Date of Acceptance: July 24, 2025
Registration Advertised: Jan. 12
For further details contact Herbert Smith Freehills Kramer.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2553325.
Disclaimer: Curated by HT Syndication.
